Canada markets closed
  • S&P/TSX

    20,329.73
    -36.12 (-0.18%)
     
  • S&P 500

    4,402.66
    -20.49 (-0.46%)
     
  • DOW

    34,792.67
    -323.73 (-0.92%)
     
  • CAD/USD

    0.7973
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    68.02
    -2.54 (-3.60%)
     
  • BTC-CAD

    49,908.80
    +1,483.21 (+3.06%)
     
  • CMC Crypto 200

    977.06
    +50.30 (+5.43%)
     
  • GOLD FUTURES

    1,809.60
    -0.50 (-0.03%)
     
  • RUSSELL 2000

    2,196.32
    -27.26 (-1.23%)
     
  • 10-Yr Bond

    1.1840
    +0.0080 (+0.68%)
     
  • NASDAQ futures

    15,081.50
    +35.25 (+0.23%)
     
  • VOLATILITY

    17.97
    -0.07 (-0.39%)
     
  • FTSE

    7,123.86
    +18.14 (+0.26%)
     
  • NIKKEI 225

    27,584.08
    -57.75 (-0.21%)
     
  • CAD/EUR

    0.6732
    +0.0010 (+0.15%)
     

Scientist.com Partners with Top CROs to Offer Disease Models for Cancer Research

·2 min read

AI-powered Disease Model Finder Helps Researchers Identify Preclinical Oncology Models

SAN DIEGO, Jun 15, 2021--(BUSINESS WIRE)--Scientist.com, the pharmaceutical industry’s leading marketplace for life science research, announced today that it has partnered with leading oncology CROs to launch a Disease Model Finder that helps medical researchers use genetic, cellular and patient data to find the most appropriate research models for their preclinical development projects.

"Our proprietary model selection software uses multiple machine learning algorithms to help researchers sift through large amounts of data and identify in vitro and in vivo models for their research," stated Javier Pineda, PhD, Data Scientist at Scientist.com. "Scientists can filter by gene mutation, gene expression, cancer type or patient information, and then purchase without delay once the right model is identified."

The Disease Model Finder brings together a wealth of data that can help scientists choose the right preclinical disease models. DNA sequencing data from CRO partners is uploaded and analyzed so that researchers can easily search for models based on the presence (or absence) of a mutated gene or by the up or down regulation of gene expression. Marketplace customers can then filter their search results based on cancer type, subtype and characteristics or patient information.

The Disease Model Finder currently includes 1,400 PDX models. By 2022, the platform will include other model systems including organoids, cell-derived xenografts (CDX), syngeneic models, immunoncology models and patient-derived cell lines.

To learn more please visit https://www.scientist.com/disease-model-finder/

About Scientist.com

Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk and provides access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 80 biotechnology companies and the US National Institutes of Health (NIH).

Visit scientist.com to learn more.

Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005450/en/

Contacts

Sean Preci
Director of Communications
+1 858 455-1300 ext. 401
marketing@scientist.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting